HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Coexistence of familial antiphospholipid syndrome and factor V Leiden: impact on thrombotic diathesis.

Abstract
Two young siblings who presented with an unusual recurrent severe thromboembolic phenomenon were found to have familial anti-phospholipid syndrome and were heterozygous for the factor V R506Q mutation. The coexistence of hereditary and acquired APC-resistance may explain the severity of thromboembolism.
AuthorsB Brenner, S L Vulfsons, N Lanir, M Nahir
JournalBritish journal of haematology (Br J Haematol) Vol. 94 Issue 1 Pg. 166-7 (Jul 1996) ISSN: 0007-1048 [Print] England
PMID8757529 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anticoagulants
  • Protein C
  • Factor V
Topics
  • Abortion, Spontaneous (etiology)
  • Adult
  • Anticoagulants (therapeutic use)
  • Antiphospholipid Syndrome (blood, complications, genetics)
  • Bone Marrow (blood supply)
  • Factor V (genetics)
  • Female
  • Femoral Artery
  • Fetal Death
  • Humans
  • Pregnancy
  • Pregnancy Complications, Cardiovascular (etiology)
  • Protein C (antagonists & inhibitors)
  • Thromboembolism (blood, etiology, genetics)
  • Thrombosis (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: